This case from pharmacotherapy casebook 9th edition Terry L.schwingammer . Julie
ID: 3476318 • Letter: T
Question
This case from pharmacotherapy casebook 9th edition Terry L.schwingammer . Julie M.KoehlerPage 109 (gastroesophagel reflux disease)
Questions: Problem Identification 1.a. Develop a list of this patient’s drug therapy problems. 1.b. Classify the GERD symptoms this patient is experiencing. Are they typical or atypical in nature? Are any alarm symptoms or features present? 1.c. What factors could be contributing to the development of GERD symptoms in this patient? 1.d. If you saw this patient in the community pharmacy setting, what factors would cause you to refer her for further diagnostic evaluation versus recommending empiric drug therapy? 1.e. What are other potential complications of long-standing untreated GERD? Problem Identification 1.a. Develop a list of this patient’s drug therapy problems. 1.b. Classify the GERD symptoms this patient is experiencing. Are they typical or atypical in nature? Are any alarm symptoms or features present? 1.c. What factors could be contributing to the development of GERD symptoms in this patient? 1.d. If you saw this patient in the community pharmacy setting, what factors would cause you to refer her for further diagnostic evaluation versus recommending empiric drug therapy? 1.e. What are other potential complications of long-standing untreated GERD?
Desired Outcome 2. Develop a list of pharmacotherapeutic goals for this patient. Therapeutic Alternatives 3.a. What lifestyle modifications or nonpharmacologic therapies may improve this patient’s GERD symptoms? Desired Outcome 2. Develop a list of pharmacotherapeutic goals for this patient. Therapeutic Alternatives 3.a. What lifestyle modifications or nonpharmacologic therapies may improve this patient’s GERD symptoms? 3.b. What drug therapies could be used to treat this patient’s GERD symptoms?
Optimal Plan 4. Develop a complete treatment plan for managing this patient’s GERD symptoms. Outcome Evaluation 5. What parameters should be monitored to assess both the efficacy and toxicity of your selected drug regimen? Patient Education 6. How will you educate the patient about her GERD therapy to enhance compliance, minimize adverse effects, and promote successful therapeutic outcomes? 3.b. What drug therapies could be used to treat this patient’s GERD symptoms?
Optimal Plan 4. Develop a complete treatment plan for managing this patient’s GERD symptoms. Outcome Evaluation 5. What parameters should be monitored to assess both the efficacy and toxicity of your selected drug regimen? Patient Education 6. How will you educate the patient about her GERD therapy to enhance compliance, minimize adverse effects, and promote successful therapeutic outcomes? Phys Gen Well-d PATIENT PRESENTATION Chief Complaint "I'm having a lot of heartburn. These pills I have been using have helped a little but it's still keeping me up at night." VS BP 139 Skin HPI Janet Swigel is a 68-year-old woman who presents to the GI clinic with complaints of heartburn four to five times a week over the st HEENT 5 months. She also reports some regurgitation after meals. She states that her symptoms are much worse at night, particularly when she goes to bed. She finds that her heartburn worsens and she coughs a lot at night, which keeps her awake. She has had difficulty sleeping over this time period and feels fatigued during the day. She reports no difficulty swallowing food or liquids. She has tried OTC PrevacidTrache 24HR once daily for the last 3 weeks. This has reduced the frequency of her symptoms to 3-4 days per week, but they are still bothering her, and she needs help. No lesi PERRI oropha Neck/Ly Lungs/ Mostly
Explanation / Answer
2. Pharmacotherapeutic goals for this patient-
Note- at a time we can answer one question or four parts of a question.